FDA NDC Directory · JSON-LD · Markdown

Everolimus

NDC 0093-7768 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA210050
Dosage form / routeTABLET · ORAL
Active ingredientsEVEROLIMUS (7.5 mg/1)
Marketing started20200610
Marketing ended20260930
Package count1

External sources

Source: openFDA. Public-domain (CC0).